Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer

Redirected chimeric antigen receptor (CAR) T-cells can recognize and eradicate cancer cells in a major histocompatibility complex independent manner. Genetic engineering of T cells through CAR expression has yielded great results in the treatment of hematological malignancies compared with solid tum...

Full description

Bibliographic Details
Main Authors: Ilnaz Rahimmanesh, Hossein Khanahmad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2021;volume=16;issue=5;spage=447;epage=454;aulast=Rahimmanesh